Rentokil Initial (LSE:RTO) Could Be 32% Below Fair Value On Half Year Results
Rentokil Initial (LSE:RTO) moved back into focus after its latest half year update, where higher revenue and profit coincided with a sharp 29.4% share price fall in 2026.
That sharp 29.4% share price decline in 2026 sits against a weak recent trend, with the 90-day share price return down 29.8% and the year-to-date share price return down 28.8%. Meanwhile, the 1-year total shareholder return has fallen 19.3%, suggesting momentum has faded even as Rentokil Initial continues to talk up cash flow and bolt-on acquisition plans.
Scan how Rentokil Initial compares with other businesses under pressure yet still backed by solid fundamentals using our curated list of 7 high quality undervalued stocks.
After a 29.4% slide in 2026 despite revenue and profit growth, Rentokil Initial now asks a simple question of investors: Does this reset leave enough upside potential to justify the risks that triggered the sell off?
Most Popular Narrative: 32% Undervalued
Rentokil Initial closed at £3.16, while the most followed valuation story puts fair value around £4.65. This frames the recent reset as a pricing question rather than a business collapse.
Cost efficiency and scalability are set to improve through branch integrations and process optimization, with management reiterating a clear path to $100 million in cost savings and the potential for North American margins to move above 20% post-2026, directly supporting higher future net margins and earnings.
See why 21 investors see Rentokil Initial as 32% undervalued.
Result: Fair Value of £4.65 (UNDERVALUED)
Still, the Rentokil Initial story hinges on cleaner execution in North America and tighter control of termite liabilities, where rising claim costs and provisions remain a real swing factor.
Find out about the key risks to this Rentokil Initial narrative.
Next Steps
Mixed sentiment around Rentokil Initial is clear, with both risk flags and upside angles in play. Move quickly and pressure test the full picture for yourself by reviewing the 4 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Rentokil Initial?
Do not stop your research with Rentokil Initial. Broaden your watchlist with targeted stock ideas that match different goals, risk levels, and income preferences.
- Target potential mispricing by scanning a curated pool of companies that combine quality fundamentals with valuation support using the 7 high quality undervalued stocks.
- Build a steadier income stream by focusing on businesses with robust yields and payout profiles through the 2 dividend fortresses.
- Ring fence downside risk by concentrating on companies screened for financial resilience and lower risk scores in the 4 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com